Hengwei Liu1, Wei Zhang1, Lili Wang2, Zhibing Zhang3,4, Wenqian Xiong5, Ling Zhang5, Tian Fu5, Xiaoou Li5, Yaobing Chen6, Yi Liu5. 1. Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China. 2. Department of Obstetrics and Gynecology, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430032, China. 3. Department of Physiology, Wayne State University, Detroit, Michigan, USA. 4. Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan, USA. 5. Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. 6. Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Abstract
BACKGROUND: Endometriosis is a benign gynecological disorder which shares certain characteristics with malignant tumor like migration, invasion and proliferation. Glioma-associated oncogene homolog 1 (GLI1) has been implicated in some cancers including endometrial cancer, however, its role in endometriosis remains unknown. METHODS: The aim of this study was to explore the expression pattern of GLI1 in endometriosis, and further investigate the effect of GLI1 regulation on human endometrial stromal cells. The expression of GLI1 in normal endometrium and ectopic tissues was analyzed by immunohistochemistry, quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blot. The Short hairpin RNA (ShRNA) intervention technique and GLI1 inhibitor GANT-61 were used to silence GLI1. The expression levels of GLI1, MMP2 and MMP9 was detected by qRT-PCR and western blot. The migration and invasion ability of human endometrial stromal cells was determined by wound healing assay and transwell migration/invasion assay. The viability and proliferation potentiality of cells was detected by MTT assays and colony formation assay, respectively. RESULTS: We found that the expression of GLI1 mRNA and protein were significantly higher in ectopic endometrium from patients with endometriosis. Our analyses also show that GLI1 downregulation attenuated cells migration, invasion and proliferation abilities. What's more, reduced expression of GLI1 inhibited the expression of matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9). CONCLUSIONS: Our findings suggest that high levels of GLI1 may contribute to the development of endometriosis by promoting cell migration, invasion and proliferation involving regulation of MMP2 and MMP9 expression. Therefore, inhibition of GLI1 might be a novel potential therapeutic approach to the treatment of endometriosis, which sheds new light on our understanding of the pathogenesis of endometriosis. 2019 Annals of Translational Medicine. All rights reserved.
BACKGROUND: Endometriosis is a benign gynecological disorder which shares certain characteristics with malignant tumor like migration, invasion and proliferation. Glioma-associated oncogene homolog 1 (GLI1) has been implicated in some cancers including endometrial cancer, however, its role in endometriosis remains unknown. METHODS: The aim of this study was to explore the expression pattern of GLI1 in endometriosis, and further investigate the effect of GLI1 regulation on human endometrial stromal cells. The expression of GLI1 in normal endometrium and ectopic tissues was analyzed by immunohistochemistry, quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blot. The Short hairpin RNA (ShRNA) intervention technique and GLI1 inhibitor GANT-61 were used to silence GLI1. The expression levels of GLI1, MMP2 and MMP9 was detected by qRT-PCR and western blot. The migration and invasion ability of human endometrial stromal cells was determined by wound healing assay and transwell migration/invasion assay. The viability and proliferation potentiality of cells was detected by MTT assays and colony formation assay, respectively. RESULTS: We found that the expression of GLI1 mRNA and protein were significantly higher in ectopic endometrium from patients with endometriosis. Our analyses also show that GLI1 downregulation attenuated cells migration, invasion and proliferation abilities. What's more, reduced expression of GLI1 inhibited the expression of matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9). CONCLUSIONS: Our findings suggest that high levels of GLI1 may contribute to the development of endometriosis by promoting cell migration, invasion and proliferation involving regulation of MMP2 and MMP9 expression. Therefore, inhibition of GLI1 might be a novel potential therapeutic approach to the treatment of endometriosis, which sheds new light on our understanding of the pathogenesis of endometriosis. 2019 Annals of Translational Medicine. All rights reserved.
Authors: Grant W Montgomery; Dale R Nyholt; Zhen Zhen Zhao; Susan A Treloar; Jodie N Painter; Stacey A Missmer; Stephen H Kennedy; Krina T Zondervan Journal: Hum Reprod Update Date: 2008-06-05 Impact factor: 15.610
Authors: Michael S Anglesio; Nickolas Papadopoulos; Ayse Ayhan; Tayyebeh M Nazeran; Michaël Noë; Hugo M Horlings; Amy Lum; Siân Jones; Janine Senz; Tamer Seckin; Julie Ho; Ren-Chin Wu; Vivian Lac; Hiroshi Ogawa; Basile Tessier-Cloutier; Rami Alhassan; Amy Wang; Yuxuan Wang; Joshua D Cohen; Fontayne Wong; Adnan Hasanovic; Natasha Orr; Ming Zhang; Maria Popoli; Wyatt McMahon; Laura D Wood; Austin Mattox; Catherine Allaire; James Segars; Christina Williams; Cristian Tomasetti; Niki Boyd; Kenneth W Kinzler; C Blake Gilks; Luis Diaz; Tian-Li Wang; Bert Vogelstein; Paul J Yong; David G Huntsman; Ie-Ming Shih Journal: N Engl J Med Date: 2017-05-11 Impact factor: 91.245
Authors: Kyung Hee Kim; Jin Man Kim; Yoon-La Choi; Young Kee Shin; Ho-chang Lee; In Ock Seong; Bum Kyung Kim; Seoung Wan Chae; Yun-Shin Chung; Seok-Hyung Kim Journal: Pathol Int Date: 2009-05 Impact factor: 2.534
Authors: Helena Malvezzi; Valéria Gomes Aguiar; Claudia Cristina Paro de Paz; José Eduardo Tanus-Santos; Ivan Andrade de Araujo Penna; Paula Andrea Navarro Journal: Reprod Sci Date: 2012-11-20 Impact factor: 3.060
Authors: F Faião-Flores; D K Alves-Fernandes; P C Pennacchi; S Sandri; A L S A Vicente; C Scapulatempo-Neto; V L Vazquez; R M Reis; J Chauhan; C R Goding; K S Smalley; S S Maria-Engler Journal: Oncogene Date: 2016-10-17 Impact factor: 9.867
Authors: Pietro Valerio Foti; Renato Farina; Stefano Palmucci; Ilenia Anna Agata Vizzini; Norma Libertini; Maria Coronella; Saveria Spadola; Rosario Caltabiano; Marco Iraci; Antonio Basile; Pietro Milone; Antonio Cianci; Giovanni Carlo Ettorre Journal: Insights Imaging Date: 2018-02-15